CompletedNot Applicable

Adenoma Detection Rate of 3D Colonoscopy

Taiwan318 participantsStarted 2022-02-10

Plain-language summary

Adenoma detection rate (ADR) has been the most important quality indicator on colonoscopy because ADR was reversely related with CRC incidence and mortality. Several image enhanced technologies, such as narrow-band imaging (NBI) or linked colour imaging (LCI) had been proved to have ability to increase the ADR. 3D techonology, however, has not been validated on colonoscopy performance. Therefore, current study was to compare the ADR between new 3D colonoscopy and conventional 2D colonoscopy.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 40 or above * Indication for colonoscopy, including screening, surveillance, symptomatic, etc Exclusion Criteria: * Poor and inadequate bowel preparation * Incomplete study because of obstructive lesion, including cancer, stenosis, etc. * Failure of cecal intubation, difficult insertion * Inflammatory bowel disease * Hereditary polyposis, (FAP, Lynch syndrome, hyperplastic polyposis, etc.)

What they're measuring

Adenoma detection rate

Timeframe: 1 week

Trial details

NCT IDNCT05153746

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-05-23

View on ClinicalTrials.gov More Colorectal Neoplasms trials